Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Capital Expenditures: 2013-2024

Historic Capital Expenditures for Collegium Pharmaceutical (COLL) over the last 12 years, with Dec 2024 value amounting to $1.7 million.

  • Collegium Pharmaceutical's Capital Expenditures fell 22.95% to $188,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 30.10%. This contributed to the annual value of $1.7 million for FY2024, which is 258.35% up from last year.
  • As of FY2024, Collegium Pharmaceutical's Capital Expenditures stood at $1.7 million, which was up 258.35% from $461,000 recorded in FY2023.
  • Over the past 5 years, Collegium Pharmaceutical's Capital Expenditures peaked at $5.5 million during FY2020, and registered a low of $461,000 during FY2023.
  • For the 3-year period, Collegium Pharmaceutical's Capital Expenditures averaged around $1.2 million, with its median value being $1.6 million (2022).
  • Per our database at Business Quant, Collegium Pharmaceutical's Capital Expenditures slumped by 71.58% in 2023 and then skyrocketed by 258.35% in 2024.
  • Over the past 5 years, Collegium Pharmaceutical's Capital Expenditures (Yearly) stood at $5.5 million in 2020, then slumped by 64.95% to $1.9 million in 2021, then decreased by 16.56% to $1.6 million in 2022, then tumbled by 71.58% to $461,000 in 2023, then surged by 258.35% to $1.7 million in 2024.